\-\ Texto\\:\\ \ \(0\)\
\-\ increased\\ signal\\ intensity\\ and\\ widening\\ of\\ the\\ optic\\ nerves\\ as\\ they\\ track\\ posteriorly\\.\ \(0\)\
\-\ there\\ is\\ a\\ well\\ circumscribed\\ 1\\.5x1cm\\ mass\\ of\\ high\\ signal\\ intensity\\ located\\ at\\ the\\ location\\ of\\ the\\ optic\\ chiasm\\.\\ \\ the\\ lesion\\ is\\ suprasellar\\.\ \(0\)\
\-\ bilateral\\ optic\\ gliomas\ \(0\)\
\-\ meningioma\\ \ \(27\)\
\-\ optic\\ glioma\\ \ \(1\)\
\-\ sarcoid\ \(163\)\
\-\ optic\\ neuritis\ \(15\)\
\-\ metastasis\ \(206\)\
\-\ lymphoma\\/leukemia\ \(2\)\
\-\ the\\ patient\\ presented\\ with\\ a\\ history\\ of\\ slowly\\ progressive\\ decreased\\ visual\\ acuity\\.\ \(0\)\
\-\ this\\ case\\ is\\ unique\\ in\\ that\\ it\\ is\\ a\\ novel\\ presentation\\ of\\ a\\ lesion\\ overwhelmingly\\ found\\ in\\ children\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ optic\\:\\ 0\\.24120158656126986\ \(0\)\
\-\ 1\\.5x1cm\\:\\ 0\\.10750632224349388\ \(0\)\
\-\ novel\\:\\ 0\\.09905330784642138\ \(0\)\
\-\ overwhelmingly\\:\\ 0\\.09905330784642138\ \(0\)\
\-\ lymphoma\\/leukemia\\:\\ 0\\.08214727905227637\ \(0\)\
\-\ intensity\\:\\ 0\\.07533343113120247\ \(0\)\
\-\ gliomas\\:\\ 0\\.06874956821486039\ \(0\)\
\-\ track\\:\\ 0\\.06825173901339388\ \(0\)\
\-\ unique\\:\\ 0\\.0664417389509759\ \(0\)\
\-\ neuritis\\:\\ 0\\.06602830539395539\ \(0\)\
\-\ acuity\\:\\ 0\\.06562842950587015\ \(0\)\
\-\ chiasm\\:\\ 0\\.06192498543516012\ \(0\)\
\-\ suprasellar\\:\\ 0\\.056788235861058856\ \(0\)\
\-\ slowly\\:\\ 0\\.056599160415498305\ \(0\)\
\-\ signal\\:\\ 0\\.05495303244567753\ \(0\)\
\-\ sarcoid\\:\\ 0\\.05347197103808761\ \(0\)\
\-\ nerves\\:\\ 0\\.05290465377424746\ \(0\)\
\-\ widening\\:\\ 0\\.05249584045670303\ \(0\)\
\-\ posteriorly\\:\\ 0\\.049224328425060596\ \(0\)\
\-\ visual\\:\\ 0\\.047242390260453584\ \(0\)\
\-\ glioma\\:\\ 0\\.0469838267525194\ \(0\)\
\-\ circumscribed\\:\\ 0\\.04631998277014114\ \(0\)\
\-\ children\\:\\ 0\\.045018956641015115\ \(0\)\
\-\ located\\:\\ 0\\.04289269582217636\ \(0\)\
\-\ lesion\\:\\ 0\\.042452566487815965\ \(0\)\
\-\ progressive\\:\\ 0\\.041188281890771984\ \(0\)\
\-\ meningioma\\:\\ 0\\.040074260200671646\ \(0\)\
\-\ metastasis\\:\\ 0\\.03900911373536496\ \(0\)\
\-\ they\\:\\ 0\\.037548123493747636\ \(0\)\
\-\ location\\:\\ 0\\.036350093742730405\ \(0\)\
\-\ presentation\\:\\ 0\\.03589512968891564\ \(0\)\
\-\ found\\:\\ 0\\.03284177578600137\ \(0\)\
\-\ decreased\\:\\ 0\\.0309848341795678\ \(0\)\
\-\ high\\:\\ 0\\.0285188544033758\ \(0\)\
\-\ presented\\:\\ 0\\.028406800427102554\ \(0\)\
\-\ is\\:\\ 0\\.027428818457791496\ \(0\)\
\-\ increased\\:\\ 0\\.025493716851215313\ \(0\)\
\-\ bilateral\\:\\ 0\\.02529046011359078\ \(0\)\
\-\ well\\:\\ 0\\.02357415796303233\ \(0\)\
\-\ it\\:\\ 0\\.02342498029918313\ \(0\)\
\-\ case\\:\\ 0\\.02279883454716184\ \(0\)\
\-\ a\\:\\ 0\\.01934633179602933\ \(0\)\
\-\ that\\:\\ 0\\.017999764982424674\ \(0\)\
\-\ as\\:\\ 0\\.015763140315782048\ \(0\)\
\-\ there\\:\\ 0\\.015508726298353521\ \(0\)\
\-\ mass\\:\\ 0\\.01449342691399469\ \(0\)\
\-\ history\\:\\ 0\\.014392860215940042\ \(0\)\
\-\ at\\:\\ 0\\.01411906283941016\ \(0\)\
\-\ this\\:\\ 0\\.011721185528221136\ \(0\)\
\-\ patient\\:\\ 0\\.01044624305995595\ \(0\)\
\-\ in\\:\\ 0\\.010277981222933047\ \(0\)\
\-\ the\\:\\ 0\\.008429834433147914\ \(0\)\
\-\ of\\:\\ 0\\.00710389029256027\ \(0\)\
\-\ and\\:\\ 0\\.002195231777222176\ \(0\)\
\-\ \\.\\:\\ 0\\.002164605859594285\ \(0\)\
\-\ with\\:\\ 0\\.0014268801962181675\ \(0\)\
